Novartis launched a major job and cost-cutting program as the Swiss pharma giant reported a weaker-than-expected 7.9% rise in third-quarter net profit. 25 Oct, 2011
--
Source: http://online.wsj.com/article/SB10001424052970204777904576652430829067302.html?mod=asia_home
~
Manage subscription | Powered by rssforward.com
--
Source: http://online.wsj.com/article/SB10001424052970204777904576652430829067302.html?mod=asia_home
~
Manage subscription | Powered by rssforward.com
No comments:
Post a Comment